R&G PharmaStudies (301333.SZ) plans to repurchase company shares with an amount ranging from 40 million to 60 million yuan.
Norsec (301333.SZ) has announced that the company plans to repurchase some of its shares with its own funds, and will use the repurchased shares for employee stock ownership plans or equity incentives. The total upper limit of the repurchase funds is 60 million yuan (including the principal), and the lower limit is 40 million yuan (including the principal). The repurchase price will not exceed 65.00 yuan per share (including the principal).
R&G PharmaStudies (301333.SZ) announced that the company plans to repurchase some of its shares with its own funds, and will use the repurchased shares for employee stock ownership plans or equity incentives. The total amount of funds for repurchasing shares has an upper limit of 60 million yuan (including the principal) and a lower limit of 40 million yuan (including the principal). The repurchase price will not exceed 65.00 yuan per share (including the principal).
Related Articles
From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.
Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.
One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)
From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.
Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.
One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)
RECOMMEND
